Cancer Genetics Inc (NASDAQ:CGIX)

0.9001
Delayed Data
As of Jun 22
 -0.0899 / -9.08%
Today’s Change
0.82
Today|||52-Week Range
4.25
-51.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues6.6M8.0M7.5M7.7M
 
 
 
 
 
Cost of Goods Sold3.5M4.1M4.7M4.5M
 
 
 
 
 
Depreciation And Amortization530.0K523.0K495.0K564.0K
 
 
 
 
 
 
Operating ExpensesGross Income2.6M3.4M2.3M2.6M
 
 
 
 
 
General Expenses5.7M6.5M11.8M7.5M
 
 
 
 
 
Research And Development982.0K979.0K1.7M679.0K
 
 
 
 
 
Total Operating Expenses9.7M11.1M17.1M12.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.1M-3.0M-9.5M-4.9M
 
 
 
 
 
Extraordinary Credit590.0K2.9M2.1M709.0K
 
 
 
 
 
Extraordinary Charge0.00-150.0K0.000.00
 
 
Pre-Tax Equity Earnings-7.0K-2.0K-1.0K-2.0K
 
 
 
 
 
Interest Expense On Debt253.0K350.0K1.4M239.0K
 
 
 
 
 
Other Expenses0.000.00-220.0K0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.8M-633.0K-9.0M-4.5M
 
 
 
 
 
Income Taxes0.000.00-1.1M0.00
 
 
Net Income-2.8M-633.0K-7.9M-4.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS19.7M21.6M27.8M27.0M
 
 
 
 
 
Shares To Calculate EPS Diluted20.7M22.4M27.8M27.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.16-$0.15-$0.35-$0.16
 
 
 
 
 
EPS Diluted-$0.16-$0.15-$0.28-$0.16